ES8308305A1 - Procedimiento para la preparacion de un peptido. - Google Patents

Procedimiento para la preparacion de un peptido.

Info

Publication number
ES8308305A1
ES8308305A1 ES517596A ES517596A ES8308305A1 ES 8308305 A1 ES8308305 A1 ES 8308305A1 ES 517596 A ES517596 A ES 517596A ES 517596 A ES517596 A ES 517596A ES 8308305 A1 ES8308305 A1 ES 8308305A1
Authority
ES
Spain
Prior art keywords
denotes
aminoacid
preparation
peptides
aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517596A
Other languages
English (en)
Other versions
ES517596A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8308305A1 publication Critical patent/ES8308305A1/es
Publication of ES517596A0 publication Critical patent/ES517596A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • C07K14/662Thymopoietins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/18Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE PEPTIDOS DE FORMULA GENERAL: B<1-B<2-A<1-A<2-X EN LA QUE B<1 SIGNIFICA UN AMINOACIDO BASICO; B<2 SIGNIFICA UN AMINOACIDO BASICO; A<1 SIGNIFICA UN AMINOACIDO AROMATICO; A<2 SIGNIFICA UN AMINOACIDO AROMATICO; Y X SIGNIFICA UN AMINOACIDO. CONSISTE EN PREPARARLOS POR ACTIVACION DE DI-, TRI- O TETRAPEPTIDOS TERMINADOS EN N, PROTEGIDOS EN N>~C, Y EN SU REACCION CON LAS PARTES TERMINALES EN C CORRESPONDIENTES. A CONTINUACION SE ELIMINAN LOS GRUPOS PROTECTORES DESDOBLABES EN CONDICIONES ACIDAS. DE APLICACION EN EL TRATAMIENTO DE DEFICIENCIAS INMUNOLOGICAS, VIRALES Y FUNGOIDEAS, ASI COMO EN EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNOLOGICAS.
ES517596A 1981-11-25 1982-11-23 Procedimiento para la preparacion de un peptido. Granted ES517596A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813146598 DE3146598A1 (de) 1981-11-25 1981-11-25 "neue peptide und verfahren zu ihrer herstellung"

Publications (2)

Publication Number Publication Date
ES8308305A1 true ES8308305A1 (es) 1983-08-16
ES517596A0 ES517596A0 (es) 1983-08-16

Family

ID=6147104

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517596A Granted ES517596A0 (es) 1981-11-25 1982-11-23 Procedimiento para la preparacion de un peptido.

Country Status (14)

Country Link
US (1) US4487764A (es)
EP (1) EP0080194B1 (es)
JP (1) JPS5892642A (es)
KR (1) KR840002346A (es)
AT (1) ATE17584T1 (es)
AU (1) AU9084682A (es)
DE (2) DE3146598A1 (es)
DK (1) DK155948B (es)
ES (1) ES517596A0 (es)
FI (1) FI824030L (es)
GR (1) GR77026B (es)
IL (1) IL67334A0 (es)
PT (1) PT75898A (es)
ZA (1) ZA828651B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2130590B (en) * 1982-11-10 1986-01-08 Erba Farmitalia Peptides
EP0215805A1 (en) * 1985-01-18 1987-04-01 MERCK PATENT GmbH Immunoregulatory peptides
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
DD292382B5 (de) * 1990-03-06 1994-03-24 Berlin Chemie Ag Verfahren zur herstellung eines parenteral applizierbaren lagerbestaendigen immunstimulierenden praeparats
US6354783B1 (en) 1999-06-03 2002-03-12 Nextrx Corporation Medication-handling system for use in loading medication carts
CN1403474A (zh) * 2001-09-05 2003-03-19 中国人民解放军军事医学科学院生物工程研究所 一种短肽及以其为活性成份的药物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073890A (en) * 1974-03-26 1978-02-14 Takeda Chemical Industries, Ltd. Novel polypeptides
US4001199A (en) * 1974-03-26 1977-01-04 Takeda Chemical Industries, Ltd. Novel polypeptides useful for treating diabetes and hypercholesteremia
GB1596535A (en) * 1977-11-23 1981-08-26 Wellcome Found Biologically-active peptides
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions

Also Published As

Publication number Publication date
KR840002346A (ko) 1984-06-25
DE3146598A1 (de) 1983-07-07
PT75898A (de) 1982-12-01
EP0080194B1 (de) 1986-01-22
GR77026B (es) 1984-09-04
DK522582A (da) 1983-05-26
EP0080194A1 (de) 1983-06-01
DK155948B (da) 1989-06-05
ES517596A0 (es) 1983-08-16
AU9084682A (en) 1983-06-02
JPS5892642A (ja) 1983-06-02
ZA828651B (en) 1983-09-28
IL67334A0 (en) 1983-03-31
FI824030L (fi) 1983-05-26
ATE17584T1 (de) 1986-02-15
US4487764A (en) 1984-12-11
FI824030A0 (fi) 1982-11-23
DE3268716D1 (en) 1986-03-06

Similar Documents

Publication Publication Date Title
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
EP0138854A4 (en) ANTIGENICALLY ACTIVE AMINO ACID SEQUENCES.
ZA867887B (en) Peptides comprising,in sequence units selected from the aminoacid residues 17 to 24 of vip
DE3569112D1 (en) 4,5-dihydro-4-oxo-2- û(2-trans-phenylcyclopropyl)amino¨-3-furancarboxylic acids and derivatives thereof
ES8703488A1 (es) Procedimiento para preparar peptidos
NO902871L (no) Fremgangsmaate for innfoering av et peptid i cytosol.
ES8308305A1 (es) Procedimiento para la preparacion de un peptido.
AU7950382A (en) Aromatic amino keto esters, pharmaceutical use
CA2018461A1 (en) Novel polypeptides and their use
AU544742B2 (en) Prepare amides especially peptides
ZA866755B (en) Soluble acrylate copolymer containing carboxyl groups,processes for its preparation and coating agents based on the acrylate copolymer
AU502568B2 (en) Preparation ofd-carbamoyl amino acids aid corresponding d-amino acids
DE3665462D1 (en) Pharmacologically active peptides
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
TW346397B (en) Cell cycle controlling compositions and methods of using same
AU5774180A (en) Alpha-halomethyl amino acids
IE880726L (en) Amino acid derivatives.
IE882973L (en) Amino acid derivatives.
IE901219L (en) Amino acid derivatives.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980401